| pubmed-article:11144397 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11144397 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11144397 | lifeskim:mentions | umls-concept:C0271429 | lld:lifeskim |
| pubmed-article:11144397 | lifeskim:mentions | umls-concept:C0060405 | lld:lifeskim |
| pubmed-article:11144397 | lifeskim:mentions | umls-concept:C0585361 | lld:lifeskim |
| pubmed-article:11144397 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:11144397 | pubmed:issue | 12 Suppl | lld:pubmed |
| pubmed-article:11144397 | pubmed:dateCreated | 2000-12-28 | lld:pubmed |
| pubmed-article:11144397 | pubmed:abstractText | To examine the microbiologic and clinical efficacy of a 5-day course of cefdinir in the treatment of tympanocentesis-documented acute otitis media (AOM). | lld:pubmed |
| pubmed-article:11144397 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11144397 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11144397 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11144397 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11144397 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11144397 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11144397 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:11144397 | pubmed:issn | 0891-3668 | lld:pubmed |
| pubmed-article:11144397 | pubmed:author | pubmed-author:KratzerJJ | lld:pubmed |
| pubmed-article:11144397 | pubmed:author | pubmed-author:TaitH PHP | lld:pubmed |
| pubmed-article:11144397 | pubmed:author | pubmed-author:HedrickJ AJA | lld:pubmed |
| pubmed-article:11144397 | pubmed:author | pubmed-author:BlockS LSL | lld:pubmed |
| pubmed-article:11144397 | pubmed:author | pubmed-author:NemethM AMA | lld:pubmed |
| pubmed-article:11144397 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11144397 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:11144397 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11144397 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11144397 | pubmed:pagination | S153-8 | lld:pubmed |
| pubmed-article:11144397 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:meshHeading | pubmed-meshheading:11144397... | lld:pubmed |
| pubmed-article:11144397 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11144397 | pubmed:articleTitle | Five-day twice daily cefdinir therapy for acute otitis media: microbiologic and clinical efficacy. | lld:pubmed |
| pubmed-article:11144397 | pubmed:affiliation | Kentucky Pediatric Research, Bardstown, USA. | lld:pubmed |
| pubmed-article:11144397 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11144397 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11144397 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11144397 | lld:pubmed |
